Financial reports
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K
2023 FY
Annual report
15 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
14 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
Current reports
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Feb 24
8-K
Unregistered Sales of Equity Securities
17 Jan 24
8-K
Unregistered Sales of Equity Securities
5 Jan 24
8-K
Unregistered Sales of Equity Securities
3 Jan 24
8-K
Unregistered Sales of Equity Securities
11 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
27 Nov 23
8-K
Entry into a Material Definitive Agreement
22 Nov 23
8-K
ZIVO Bioscience Announces Reverse Stock Split
26 Oct 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9 Aug 23
8-K
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
6 Jul 23
Registration and prospectus
25-NSE
Exchange delisting
15 Feb 24
RW
Registration withdrawal request
1 Dec 23
S-1/A
IPO registration (amended)
3 Nov 23
S-1/A
IPO registration (amended)
31 Oct 23
S-1
IPO registration
4 Oct 23
424B3
Prospectus supplement
3 Aug 23
S-3
Shelf registration
27 Jul 23
D
$4.00 mm in options / securities to be acquired, sold $4.00 mm, 1 investor
17 Jul 23
424B5
Prospectus supplement for primary offering
5 Jul 23
RW
Registration withdrawal request
28 Jun 23
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
DEF 14A
Definitive proxy
28 Apr 23
DEF 14A
Definitive proxy
5 Jul 22
DEFA14A
Additional proxy soliciting materials
22 Sep 21
DEF 14A
Definitive proxy
13 Sep 21
DEFR14A
Revised proxy
19 Oct 20
PRER14A
Preliminary revised proxy
8 Oct 20
DEF 14A
Definitive proxy
29 Apr 20
DEFA14A
Additional proxy soliciting materials
29 Apr 19
Other
EFFECT
Notice of effectiveness
4 Aug 23
CORRESP
Correspondence with SEC
1 Aug 23
UPLOAD
Letter from SEC
31 Jul 23
EFFECT
Notice of effectiveness
7 Sep 21
CORRESP
Correspondence with SEC
1 Sep 21
UPLOAD
Letter from SEC
31 Aug 21
EFFECT
Notice of effectiveness
28 May 21
CERT
Certification of approval for exchange listing
27 May 21
CORRESP
Correspondence with SEC
26 May 21
CORRESP
Correspondence with SEC
26 May 21
Ownership
SC 13D/A
STROME MEZZANINE FUND, LP
9 Apr 24
SC 13D
Maggiore Christopher D.
22 Jan 24
4
Alison A Cornell
4 Jan 24
4
Christopher D. Maggiore
2 Jan 24
4
Christopher D. Maggiore
14 Dec 23
4
MARK E STROME
30 Oct 23
SC 13D/A
STROME MEZZANINE FUND, LP
30 Oct 23
4
Alison A Cornell
14 Jun 23
4
Christopher D. Maggiore
14 Jun 23
4
Nola E Masterson
14 Jun 23